General Information of This Drug (ID: DMGXENV)

Drug Name
Saxagliptin   DMGXENV
Synonyms
Onglyza; BMS 477118-11; BMS-477118; Kombiglyze XR (TN); OPC-262; Onglyza (TN); BMS-477118-11; (1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3
Indication
Disease Entry ICD 11 Status REF
Type-2 diabetes 5A11 Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

9 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Dapagliflozin + Saxagliptin DC42707 Dapagliflozin Type 2 Diabetes Mellitus [2]
Metformin + Saxagliptin DCJZJ9F Metformin Type 2 Diabetes [3]
Metformin + Saxagliptin DCY4K9C Metformin Type 2 Diabetes Mellitus [4]
Sildenafil + Saxagliptin DC3X8FD Sildenafil Diabetes Mellitus, Type 2 [5]
Saxagliptin + Acarbose DCTED2T Acarbose Type 2 Diabetes [6]
Glimepiride + Saxagliptin DCX4F13 Glimepiride Type 2 Diabetes [7]
Saxagliptin + Saxagliptin DCEB4LO Saxagliptin Diabetes Mellitus, Non-Insulin-Dependent [8]
Saxagliptin + Exenatide DC5KBFV Exenatide Prediabetes [9]
Saxagliptin + Acarbose DCIF1RC Acarbose Type 2 Diabetes Mellitus [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 DrugCom(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6316).
2 ClinicalTrials.gov (NCT01662999) Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants
3 ClinicalTrials.gov (NCT00661362) Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes
4 ClinicalTrials.gov (NCT00897390) Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B)
5 ClinicalTrials.gov (NCT04170790) Evaluation of Drug Interactions of Saxagliptin With Sildenafil in Healthy Volunteers
6 ClinicalTrials.gov (NCT02315495) Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes
7 ClinicalTrials.gov (NCT02280486) Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With Metformin
8 ClinicalTrials.gov (NCT02481479) Saxagliptin and Cardiac Structure and Function
9 ClinicalTrials.gov (NCT02104739) Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
10 ClinicalTrials.gov (NCT02605772) Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes